Prognostic relevance of risk groups in the pediatric AML-BFM trials 93 and 98

Ann Hematol. 2004:83 Suppl 1:S112-6. doi: 10.1007/s00277-004-0850-2.

Authors

U Creutzig¹, D Reinhardt, M Zimmermann; AML-BFM Study Group

Affiliation

¹ University Children's Hospital, Department of Hematology/Oncology, Münster, Germany.

PMID: 15124699
DOI: 10.1007/s00277-004-0850-2

No abstract available

MeSH terms

Acute Disease
Child
Child, Preschool
Disease-Free Survival
Female
Follow-Up Studies
Humans
Infant
Karyotyping
Leukemia, Myeloid / classification
Leukemia, Myeloid / genetics
Leukemia, Myeloid / mortality
Leukemia, Myeloid / therapy*
Male
Survival Rate
Time Factors